Unipharm

Company Overview

Snapshot

Founded in July 1975 by Zvulun Tomer, Unipharm operates with 51–200 employees. The company focuses on the development, manufacturing, and marketing of generic pharmaceuticals, maintaining a mature stage in the market.

Business overview

Unipharm develops, manufactures, and markets generic pharmaceuticals, offering a broad portfolio of high-quality products across major therapeutic areas such as mental health, heart health, sleep disorders, Alzheimer's disease, osteoporosis, infectious diseases, urology, and ophthalmology. The company's drugs are produced at its EU-GMP-certified manufacturing plant in Mavo Carmel Industrial Park, Israel, serving markets in Europe, Central America, Israel, Southeast Asia, North America, and South America within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Unipharm's primary business?

Unipharm specializes in the development, manufacturing, and marketing of generic pharmaceuticals.

When was Unipharm founded?

Unipharm was founded in July 1975.

Where are Unipharm's manufacturing operations located?

Unipharm's drugs are manufactured at its EU-GMP-certified plant in Mavo Carmel Industrial Park, Israel.

What therapeutic areas does Unipharm's product portfolio cover?

Unipharm's product portfolio covers major therapeutic areas including mental health, heart health, sleep drugs, Alzheimer's disease, osteoporosis, infectious diseases, urology, and ophthalmology.

In which geographic markets does Unipharm operate?

Unipharm serves geomarkets including Europe, Central America, Israel, Southeast Asia, North America, and South America.